Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 11.


Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue
et al (show 18 more authors) (2018) CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. LANCET HAEMATOLOGY, 5 (5). E190-E200.


Primrose, John N, Fox, Richard P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg
et al (show 19 more authors) (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. LANCET ONCOLOGY, 20 (5). pp. 663-673.


Backen, Alison C, Lopes, Andre, Wasan, Harpreet, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Duggan, Marian, Cunningham, David, Anthoney, Alan, Corrie, Pippa G, Madhusudan, Srinivasan, Maraveyas, Anthony
et al (show 9 more authors) (2018) Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. British Journal of Cancer, 119 (1). pp. 27-35.


Del Chiaro, Marco, Besselink, Marc G, Scholten, Lianne, Bruno, Marco J, Cahen, Djuna L, Gress, Thomas M, van Hooft, Jeanin E, Lerch, Markus M, Mayerle, Julia, Hackert, Thilo
et al (show 80 more authors) (2018) European evidence-based guidelines on pancreatic cystic neoplasms. GUT, 67 (5). pp. 789-804.


Ghaneh, Paula, Palmer, Daniel, Cicconi, Silvia, Jackson, Richard, Halloran, Christopher Michael ORCID: 0000-0002-5471-4178, Rawcliffe, Charlotte, Sripadam, Rajaram, Mukherjee, Somnath, Soonawalla, Zahir, Wadsley, Jonathan
et al (show 26 more authors) (2022) Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. The lancet. Gastroenterology & hepatology, 8 (2). S2468-1253(22)00348-X-S2468-1253(22)00348-X.


Ghaneh, Paula, Hanson, Robert, Titman, Andrew, Lancaster, Gill, Plumpton, Catrin, Lloyd-Williams, Huw, Yeo, Seow Tien, Edwards, Rhiannon Tudor, Johnson, Colin, Abu Hilal, Mohammed
et al (show 30 more authors) (2018) PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. HEALTH TECHNOLOGY ASSESSMENT, 22 (7). 1-+.


Jones, Robert P ORCID: 0000-0001-5608-001X, Psarelli, Eftychia-Eirini ORCID: 0000-0002-3102-0288, Jackson, Richard, Ghaneh, Paula, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Campbell, Fiona, Valle, Juan W, Faluyi, Olusola, O'Reilly, Derek A
et al (show 92 more authors) (2019) Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154 (11). pp. 1038-1048.


Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J, James, Martin W, Sturgess, Richard, Stubbs, Clive, Stocken, Deborah D, Wall, Lucy, Watkinson, Anthony
et al (show 8 more authors) (2017) Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2 (8). pp. 565-575.


Hickey, Graeme L ORCID: 0000-0002-4989-0054, Grant, Stuart W, Freemantle, Nick, Cunningham, David, Munsch, Christopher M, Livesey, Steven A, Roxburgh, James, Buchan, Iain ORCID: 0000-0003-3392-1650 and Bridgewater, Ben
(2014) Surgeon length of service and risk-adjusted outcomes: linked observational analysis of the UK National Adult Cardiac Surgery Audit Registry and General Medical Council Register. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 107 (9). pp. 355-364.


Middleton, Gary, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony ORCID: 0000-0001-8547-1730, Shaw, Victoria E ORCID: 0000-0002-0429-0186, Wadsley, Jonathan, Valle, Juan W
et al (show 14 more authors) (2017) Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18 (4). pp. 486-499.


Aughton, Karen ORCID: 0000-0002-5184-5789, Elander, Nils O, Evans, Anthony ORCID: 0000-0001-8547-1730, Jackson, Richard, Campbell, Fiona, Costello, Eithne, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Mackey, John R, Scarfe, Andrew G, Valle, Juan W
et al (show 16 more authors) (2021) hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. CANCERS, 13 (22). 5758-.

This list was generated on Sat Oct 14 09:34:33 2023 BST.